Novo Nordisk Partners with Anthropic to Bring AI Deeper into Drug Discovery

AnthropicSeptember 21, 2026en

Anthropic

AI Global Wire

Novo Nordisk A/S (NYSE:NVO) has partnered with Anthropic to use Claude models and Claude Science in its research and development workflows, with the initial focus on specific scientific problems where AI can have the greatest impact.

This is a short summary published by AI Global Wire. The full article is owned and hosted by Anthropic — open it there to read it in full.

• Anthropic
• Forskning